Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

New hypocholesterolemic polymers developed at Taisho

Dec. 11, 2003

Sumitomo patent covers new antidiabetic PPARalpha and/or PPARgamma agonists

Dec. 11, 2003

S-40503: a novel SARM with selective effects on bone in rat models of osteoporosis

Dec. 10, 2003

Development agreement for MDTS formulations of Nestorone

Dec. 10, 2003

Antiobesity effects of IL-6 in rodents

Dec. 10, 2003

ETC-1001 safe and well tolerated in phase I study

Dec. 9, 2003

Yamanouchi scientists prepare and test new glycogen phosphorylase inhibitors

Dec. 9, 2003

Barr to acquire Endeavor assets

Dec. 5, 2003

Barr begins Seasonale promotion

Dec. 5, 2003

Wyeth claims new agents able to inhibit PEPCK production and lower glucose and insulin levels

Dec. 5, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...